Recently, according to drug company Novo Nordisk, the US Food and Drug Administration （FDA）approved（批准）Wegovy for children who are 12 and over．This weight loss drug has been shown to-encourage weight loss in-people struggling with obesity（肥胖），and this approval smooths the way for teenagers tousle the drug as part of a weight loss way as well.
Teenagers that have a BMI（体重指数）in the top 5％ of their age group will become eligible for a once-a-week use of the drug to go along with a meal plan for reduced calorie intake as well as an exercise plan.
In June 2021,the drug was approved by the FDA for people aged 18 and up with obesity to use,' Now, it will be available for teenagers from age 12 and up.
The teen obesity in the US continues to rise, affecting teens and their family. Now, more than ever, we need new choices to support teens. This FDA approval offers an additional tool to deal with this serious and long-lasting disease.
However, many experts have made it clear that while the drug can be a helpful additional tool, it should not be looked at as a cure-all medicine and neither should a weight loss drug.
Tom Sanders, Professor Emeritus of Nutrition and Dietetics at King's College London shared, "While drugs like this may prove useful in the short term for achieving rapid weight loss in serious obesity, they are not a cure-all medicine for preventing or treating less serious degrees of obesity; public health measures that encourage behavioral changes such as regular physical activity and balanced diets are still needed. It is rather like the situation we are in with the vaccine（疫苗）-we still need to stick with public health measures and should not depend too heavily on medicines. "
